Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 375 of 1958 entries
View as:

A Study of the Treatment of Postmenopausal Women With Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT00543023 Org: User:
Start: 06/30/03 End: 08/31/04 Due: 08/31/05

Study of Tabalumab (LY2127399) in Japanese Participants With Relapsed or Refactory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01556438 Org: User:
Start: 07/31/12 End: 08/31/15 Due: 08/31/16

Safety and Efficacy of Olanzapine in the Long-term Treatment for Bipolar I Disorder, Depressed

Phase: N/A Priority: Normal
NCT ID: NCT00618748 Org: User:
Start: 02/29/08 End: 09/30/10 Due: 09/30/11

A Study in Erectile Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00833638 Org: User:
Start: 02/28/09 End: 06/30/09 Due: 06/30/10

A Study of the Effects of Multiple Doses of LY3372689 on the Brain in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04392271 Org: User:
Start: 08/06/20 End: 10/14/20 Due: 10/14/21

Disposition of Carbon-14-Labeled LY2886721 ([^14C]-LY2886721) Following Oral Administration in Healthy Human Participants

Phase: N/A Priority: Normal
NCT ID: NCT01367262 Org: User:
Start: 06/30/11 End: 07/31/11 Due: 07/31/12

Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00063141 Org: User:
Start: 04/30/03 End: 10/31/07 Due: 10/31/08

A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)

Phase: N/A Priority: Normal
NCT ID: NCT05738486 Org: User:
Start: 02/28/23 End: 05/31/25 Due: 05/31/26

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide

Phase: N/A Priority: Normal
NCT ID: NCT00560417 Org: User:
Start: 11/30/07 End: 12/31/09 Due: 12/31/10

A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder

Phase: N/A Priority: Normal
NCT ID: NCT06817356 Org: User:
Start: 02/06/25 End: 08/31/26 Due: 08/31/27

A Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01825876 Org: User:
Start: 04/30/13 End: 06/30/13 Due: 06/30/14

Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003669 Org: User:
Start: 11/30/98 End: 04/30/01 Due: 04/30/02

Treatment for Aggression and Agitation in Patients With Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00843518 Org: User:
Start: 02/28/09 End: 06/30/11 Due: 06/30/12

A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT06809400 Org: User:
Start: 02/18/25 End: 11/30/27 Due: 11/30/28

A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT05433584 Org: User:
Start: 08/01/22 End: 11/30/27 Due: 11/30/28

Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:

Phase: N/A Priority: Normal
NCT ID: NCT02439320 Org: User:
Start: 04/30/15 End: 08/31/16 Due: 08/31/17

A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight

Phase: N/A Priority: Normal
NCT ID: NCT06124807 Org: User:
Start: 11/17/23 End: 05/31/25 Due: 05/31/26

Atomoxetine to Treat Asian Adult Patients With Attention-Deficit/Hyperactivity Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00962104 Org: User:
Start: 08/31/09 End: 02/28/11 Due: 02/28/12

A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT04809220 Org: User:
Start: 04/13/21 End: 04/26/23 Due: 04/26/24

A Study of LY3537031 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04648865 Org: User:
Start: 12/09/20 End: 06/04/21 Due: 06/04/22

Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose

Phase: N/A Priority: Normal
NCT ID: NCT01300260 Org: User:
Start: 02/28/11 End: 08/31/11 Due: 08/31/12

Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen

Phase: N/A Priority: Normal
NCT ID: NCT00332553 Org: User:
Start: 02/28/02 End: 05/31/04 Due: 05/31/05

A Study for the Treatment of Diabetic Peripheral Neuropathic Pain

Phase: N/A Priority: Normal
NCT ID: NCT00552175 Org: User:
Start: 11/30/07 End: 03/31/09 Due: 03/31/10

A Study of LY2484595 in Patients With High LDL-C or Low HDL-C

Phase: N/A Priority: Normal
NCT ID: NCT01105975 Org: User:
Start: 04/30/10 End: 06/30/11 Due: 06/30/12

A Study of LY3454738 in Healthy Participants and Participants With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03750643 Org: User:
Start: 11/29/18 End: 09/07/21 Due: 09/07/22